Things
This is a call which aims to encourage the expansion of the HEAL ITALIA Extended Partnership network (“Health Extended ALLiance for Innovative Therapies, Advanced Lab-research, and Integrated Approaches of Precision Medicine” – HEAL ITALIA, using the resources of the National Recovery and Resilience Plan (PNRR) Mission 4 “Education and Research” – Component 2 “From Research to Business”), through the involvement of external parties, strongly interested in introducing/implementing significant innovations that act as a trailblazer and/or or as a tool for accelerating and specializing the activities carried out by the Spokes for the search for technologically advanced solutions, in relation to products, processes and services transferable to the areas of intervention of Precision Medicine. The Call supports proposals relating to activities that require a level of technological maturity TRL 3 – 8 and which in any case reach a level exceeding TRL 3 at the end of the activities. Support therefore from the first phases of research (the HEAL ITALIA Program is active for less than a year) mainly referring to the development/implementation of technologies with extremely advanced content, including conceptual verification and prototypes for technology validation, demonstration activities for pilot projects and feasibility studies also in order to be able to evaluate high-performance activities high potential and support the creation of spin-offs and start-ups.
Who is it aimed at?
Subjects external to the extended HEAL ITALIA partnership identified as: • Micro, Small and Medium Enterprises (MSMEs) competing individually or collaboratively with other enterprises, having the parameters dimensions referred to in Annex I of REG (EC) no. 800/2008 of the Commission of 6 August 2008 (General block exemption regulation) in OJEU L 214 of 9.8.2008; • innovative startups established no more than 24 months ago (art. 25 of Legislative Decree 179/2012 - startup.registroimprese. it);• Large Enterprises (GI) • Foreign companies that undertake to establish at least one operational headquarters on Italian territory;• Public Administrations;• National Health Service Bodies;• Universities and bodies supervised by the MUR • Research Bodies registered with the ANR; • Public and private foundations, registered with the ANR, with recognition of legal personality and a statute in which the carrying out of Research & Innovation activities is indicated among the fundamental objectives; • Consortium companies and Consortia with an international scope, provided that at least one partner has an operational unit in Italy.
What does it predict
The Call promotes research activities on two specific topics. The first related to the study and analysis of genomic and metabolic markers, analyzing normal subjects and patient cohorts. Carry out Big Data analysis and their integration with clinical aspects. The final aim is the identification of new therapeutic targets; the second inherent to the identification of the molecular mechanisms (regulation of RNA and mitochondrial functions) that lead to the development of the Big Killers (tumors, cardiovascular diseases) with particular attention to the interaction with the environment and lifestyles. The final aim is the identification of new therapeutic targets.
